This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Illinois Attorney General (AG) Kwame Raoul and Minnesota AG Keith Ellison have joined the Federal Trade Commission (FTC) in a lawsuit to block the acquisition of Surmodics Inc. by GTCR BC Holdings LLC, two major manufacturers of critical medical device coatings.
When most people think of privateequity, manufacturing isn’t usually the first industry that comes to mind. According to PrivateEquity Info , over the past two years, there have been more than 1,060 manufacturing-focused privateequity transactions , a surprising figure that underscores the sector’s enduring appeal.
With ongoing demand for specialty drugs, biologics, and generics, privateequity sees long-term value in platforms that can scale and innovate within FDA-compliant environments. Medical Equipment and Supplies Manufacturing From surgical instruments to diagnostic devices, this sector is central to modern healthcare delivery.
Structural Growth in Key End Markets End markets like aerospace, medical devices, advanced electronics, and defense demand extreme precision, tight tolerances (±0.0001″), and rigorous certifications. PrivateEquity Dry Powder and Vertical Deals Privateequity firms hold over $1.2
2025 Dental Transactions Update As of June 2025, our research shows approximately 130 privateequity backed DSOs operating across the dental services landscape – more than in any other healthcare vertical. DSO Creation Privateequity investment in dental practices began in the 1990’s when the first DSOs sought outside investors.
Gainline Capital Partners has announced its acquisition of M&M International. M&M, founded in 1993 and based in South Plainfield, New Jersey, manufactures stainless steel tubing primarily for medical devices. By: McGuireWoods LLP
On March 6, 2025, the Federal Trade Commission (FTC) filed a lawsuit in federal court challenging GTCR BC Holdings, LLC's (GTCR) proposed acquisition of Surmodics, Inc. Surmodics). By: Goodwin
Avista Healthcare Partners has announced the acquisition of EBI. EBI, launched in 1979 and based in Parsippany, New Jersey, is a division of Highridge Medical that offers a portfolio of implantable and non-invasive bone growth stimulation solutions. By: McGuireWoods LLP
Privateequity funds have become major players in the professional health care delivery sector in recent years due to acquisitions of professional practices, including physician practices, senior living facilities and the like. Acquisitions of professional practices by privateequity funds involve myriad.
In the pursuit of attractive equity returns, privateequity firms have developed numerous innovative strategies beyond typical leveraged buyouts and take-private transactions. As it happens, this is an industry that has experienced a significant amount of privateequity-backed roll-up activity.
Marena , founded in 1994 and based in Lawrenceville, Georgia, is a manufacturer of medical-grade compression garments, specializing in post-surgical recovery solutions for invasive and non-invasive surgeries, mastectomy, maternity and post-pregnancy, and lipedema. hide - hide Back to Top Home What Is JD Supra?
medical technology (medtech) sector is experiencing robust growth and transformation, making it an increasingly attractive target for investment. Read More » The post MedTech: Why PrivateEquity Is Betting Big appeared first on Align BA. above prepandemic rates. Demand is buoyed by strong healthcare fundamentals, as U.S.
When you hear the words “healthcare privateequity,” two thoughts probably come to mind: Wait a minute, isn’t healthcare a risky/growth-oriented sector? In most of the world, healthcare is either government-run or a mixed public/private sector. Are there many private healthcare companies for PE firms to acquire?
For top privateequity firms, there’s a lot to like about SaaS. While these are just a handful of reasons why PEs love SaaS companies , it’s no wonder that top PE firms continue to focus on SaaS acquisitions. Thoma Bravo According to DealRoom , Thoma Bravo is listed as the eighth-largest global privateequity firm.
We are seeing an increasing amount of privateequity entering the veterinary space, both at the clinic level and the pet product level. Privateequity is already investing heavily in the pet industry, and it is expected to continue to grow. making it highly competitive to get into.
The 6th annual Midwest M&A/PrivateEquity Forum sponsored by the Thomson Reuters Institute was held in early December in Columbus, Ohio, and for your humble correspondent, this was not only my second time as one of the participants, but my first time as a moderator of a panel! More on that later.
This article focuses on how medical practices are valued by privateequity-backed groups, and to an extent, health systems and other strategic acquirers. Emergency medicine, radiology, and anesthesiology groups may also be candidates for acquisition by longer-established acquirers. We explore each in turn below.
CHICAGO, IL - February 6, 2023 – Sun Acquisitions is pleased to announce the successful sale of Trouvaille Med Spa to MedSpa Partners Inc. Through the acquisition of Trouvaille Med Spa, MedSpa Partners Inc. Through the acquisition of Trouvaille Med Spa, MedSpa Partners Inc. About MedSpa Partners Inc.
The platform includes the acquisitions of GEM Manufacturing, Coining MFG, National Manufacturing Co. Targeting sectors with rigorous technical specifications, regulatory compliance standards, and exacting quality requirements, MSK serves customers primarily in the medical, aerospace & defense and telecommunications end markets.
With over 15 years of experience in the technology industry, Kurt has a deep understanding of how technology applies to mergers and acquisitions. rn Summary: rn Kurt Stein discusses the role of technology, specifically artificial intelligence (AI), in mergers and acquisitions. Let's dive in.
Serving a variety of end markets, including aerospace & defense, electronics and industrials, National offers especially deep experience in the medical end market across various implantable devices, including pacemakers, neuromodulation devices, defibrillators, batteries and capacitors. appeared first on FOCUS.
3 spot on The Deal’s privateequity league table for law firms. The combination with Waller gave Holland & Knight increased capabilities in healthcare, well as in privateequity, financial services, real estate and litigation. As of March, the merged entity had nearly 2,000 attorneys in 34 offices in the U.S.
Summary Privateequity-backed Physician Practice Management (“PPM”) companies in the ENT & Allergy space continued a conservative growth trajectory during Q1 2024. Most platforms are seeking acquisitions in their home regions and are especially interested in larger, more diversified practices.
The New York Times: Mergers, Acquisitions and Dive
JUNE 23, 2024
People have grown more attached to their pets — and more willing to spend money on them — turning animal medicine into a high-tech industry worth billions.
On April 23 a group led by privateequity firm TPG agreed to acquire OneOncology, the nation’s largest independent community oncology network, in a deal valued at $2.1 While the biggest recent deal, OneOncology is hardly the first oncology platform to be sold to a privateequity group. US Oncology Network.
Excolere Equity Partners is a leading middle market privateequity firm that leverages its deep sector experience and strategic and operational expertise to accelerate the growth and enhance the impact of companies in the Education and Human Capital sector. ISP Schools is a portfolio company of OMERS PrivateEquity.
Update on PrivateEquity and Insurance Brokerages In our ,, previous article , we reported that the COVID-19 pandemic had not diminished the pace of mergers and acquisitions transactions we are seeing in the insurance agency and brokerage sector. Privateequity firms continue to drive transaction pace and value.
Washington, DC, (September 27, 2024) – FOCUS Investment Banking (“FOCUS”), a national middle market investment banking firm providing merger, acquisition, divestiture, and corporate finance services, announced today that Dulles Eye Associates has joined ReFocus Eye Health as a supported practice.
They are among the most active advisors to medical professionals in transactions with privateequity-backed organizations. FOCUS managing directors Eric Yetter and Andy Snyder advised Mid-Michigan ENT in this partnership.
For example, while a pharmaceutical company focused solely on shareholder value might prioritize high-margin drugs for rare conditions, a stakeholder-oriented approach might consider affordability and broader societal health needs , as seen with Gilead's approach to its HIV medications.
January 9, 2024 2023: A Year of Strategic Consolidation and Diversification In 2023, the Healthcare IT sector witnessed a significant transformation marked by strategic mergers and acquisitions (M&A). Billion): Privateequity firm Thoma Bravo acquired NextGen Healthcare for an enterprise value of $1.8
Summary Privateequity’s investments in ophthalmology are entering a new, more mature lifecycle phase. We also expect many platform recapitalizations once privateequity groups and lenders become comfortable with the interest rate environment. The typical ophthalmology PPM is also regionally focused. A third group (e.g.,
They are among the most active advisors to medical professionals in transactions with privateequity-backed organizations. “We Parallel ENT & Allergy is backed by Trinity Hunt Partners , a growth-oriented privateequity firm with deep healthcare experience. “We who serves as Michigan ENT’s managing partner.
Washington, DC, (August 15, 2023) – FOCUS Investment Banking (“FOCUS”), a national middle market investment banking firm providing merger, acquisition, divestiture and corporate finance services, announced today that it has added two new managing directors, Mike McCraw and William R. Bill”) Snow.
As the Federal Reserve moves toward a more predictable and potentially lower rate trajectory, financing conditions are expected to improve, enabling both strategic buyers and privateequity investors to pursue transactions with greater confidence.
Periculum Capital Company, LLC is pleased to announce it has advised Micro-Dyn Medical Systems, Inc., a leading health care software company, in its acquisition by The Brydon Group. based privateequity investor that specializes in acquiring software businesses in partnership with top mid-career executives.
focuses on the healthcare services, medical device and healthcare IT sectors. .- and Cincinnati-based RC Capital tapped McDermott Will & Emery LLP for legal advice. RC Capital, which has offices in Cincinnati and Raleigh, N.C., In 2022 it was raising its seventh fund with a $300 million target.
For example, in the biopharma space, AbbVie, Bristol Myers Squibb, AstraZeneca, and Roche each announced multiple big-ticket acquisitions in the fourth quarter – including Abbvie’s acquisition of ImmunoGen for $10.1 billion; Bristol Myer Squibb’s acquisition of RayzeBio for $4.1 billion and Cerevel Therapeutics for $8.7
The fund will not invest in hardware, medical devices or consumer social networks. Entrée Capital Entrée Capital invests predominantly in software, with a current focus in enterprise, SaaS, marketplaces, big data and fintech. Entrée Capital provides multi-stage funding for innovative seed, early and growth companies all over the world.
In turn, it has led to a surge of mergers and acquisitions in the Government software space, particularly for SaaS businesses. As an M&A advisor, Software Equity Group keeps a close eye on this space , and we’ve been deeply engaged in our own right, advising on more than 20 Government transactions for our clients in recent years.
John Prothrow had a background in mergers and acquisitions and had worked on the buy side of transactions. The brand also receives many medical referrals from podiatrists and other foot specialists. He also acquired a competitor called Happy Feet Plus in Florida, which has been a good acquisition for the brand.
CORE, a privateequity firm focused on manufacturing, industrial technology, and industrial services, previously acquired GEM, a provider of precision deep-drawn metal components and mechanical assemblies, in February 2023. PMP”), a provider of specialty stamping and machining services. FOCUS represented CORE in this transaction.
billion tie-up between Inmarsat and Viasat was cleared by both regulators, Adobe’s $20 billion proposed acquisition of Figma was abandoned in December 2023 following regulatory pressure. For example, while the $7.3
We organize all of the trending information in your field so you don't have to. Join 38,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content